Open | - |
Close | - |
Volume / Avg. | 0 / 1.489M |
Day Range | - - - |
52 Wk Range | 3.600 - 28.150 |
Market Cap | $737.633M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 12.05% |
Days to Cover | 4.96 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Longboard Pharmaceuticals (NASDAQ: LBPH) through any online brokerage.
Other companies in Longboard Pharmaceuticals’s space includes: Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), WAVE Life Sciences (NASDAQ:WVE), Verona Pharma (NASDAQ:VRNA) and Tarsus Pharmaceuticals (NASDAQ:TARS).
The latest price target for Longboard Pharmaceuticals (NASDAQ: LBPH) was reported by HC Wainwright & Co. on Friday, March 15, 2024. The analyst firm set a price target for 60.00 expecting LBPH to rise to within 12 months (a possible 192.97% upside). 21 analyst firms have reported ratings in the last year.
The stock price for Longboard Pharmaceuticals (NASDAQ: LBPH) is $20.48 last updated March 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Longboard Pharmaceuticals.
Longboard Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Longboard Pharmaceuticals.
Longboard Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.